slimvictor
Bluelight Crew
A compound found in marijuana could soon be tested on young Australians to prevent and treat psychosis after European research suggested it could treat schizophrenia with fewer side effects than other drugs.
As state and federal governments face increasing calls for the legalisation of medicinal cannabis, leading psychiatrist and mental health advocate Patrick McGorry said one part of the drug was showing promise as an anti-psychotic medicine.
The director of Orygen Youth Health Research Centre said while tetrahydrocannabinol (THC) in cannabis was widely thought to be dangerous and increase the risk of psychosis in about 10 per cent to 20 per cent of people, another component - cannabidiol (CBD) - appeared to relieve psychosis, depression and anxiety.
He said his team was hoping to trial pharmaceutical CBD in young people showing signs of early psychosis to see how it compared to other antipsychotic medications, which often cause undesirable side effects.
"There's been a lot more concern in recent times about antipsychotic medication. Obviously it's really effective, but the longer term side effects are worrying people, especially weight gain and metabolic problems, so the ethical climate has changed a bit," Professor McGorry said.
"People are willing to try more experimental treatments that have got some promise and cannabidiol is definitely one of those."
Read more: http://www.smh.com.au/national/heal...ung-people-20140826-108p12.html#ixzz3BVi9ojte
As state and federal governments face increasing calls for the legalisation of medicinal cannabis, leading psychiatrist and mental health advocate Patrick McGorry said one part of the drug was showing promise as an anti-psychotic medicine.
The director of Orygen Youth Health Research Centre said while tetrahydrocannabinol (THC) in cannabis was widely thought to be dangerous and increase the risk of psychosis in about 10 per cent to 20 per cent of people, another component - cannabidiol (CBD) - appeared to relieve psychosis, depression and anxiety.
He said his team was hoping to trial pharmaceutical CBD in young people showing signs of early psychosis to see how it compared to other antipsychotic medications, which often cause undesirable side effects.
"There's been a lot more concern in recent times about antipsychotic medication. Obviously it's really effective, but the longer term side effects are worrying people, especially weight gain and metabolic problems, so the ethical climate has changed a bit," Professor McGorry said.
"People are willing to try more experimental treatments that have got some promise and cannabidiol is definitely one of those."
Read more: http://www.smh.com.au/national/heal...ung-people-20140826-108p12.html#ixzz3BVi9ojte